Differences in p53 gene polymorphisms between Korean schizophrenia and lung cancer patients

Schizophrenia Research

Volumn 67, Issue 1, 2004, Pages 71-74

  Park, J K ^a   Lee, H J ^b   Kim, J W ^b   Park, Y H ^c   Lee, S S ^d   Chang, H I ^a   Song, J Y ^a   Yoon, D J ^a   Bahn, G H ^a   Shin, Y H ^a   Kim, Y J ^b   Kim, S A ^b   Choe, B K ^b   Kim, C J ^b   Chung, J H ^b  

^a Kyung Hee University College of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Korea Cancer Center Hospital   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Lung cancer; p53 gene; Polymorphisms; Schizophrenia

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HEREDITY; HUMAN; INTRON; KOREA; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESTRICTION SITE; SCHIZOPHRENIA;

EID: 9144265683     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(03)00155-5     Document Type: Article

References (13)

1. Biros E., Kalina I., Kohut A., Stubna J., Salagovic J. Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer. Lung Cancer. 31:2001;157-162.
2. Catts V.S., Catts S.V. Apoptosis and schizophrenia: is the tumor suppressor gene, p53, a candidate susceptibility gene? Schizophr. Res. 41:2000;405-415.
3. Cohen M.E., Dembling B., Schorling J.B. The association between schizophrenia and cancer: a population-based mortality study. Schizophr. Res. 57:2002;139-146.
4. Freedman R., Leonard S., Olincy A., Kaufmann C.A., Malaspina D., Cloninger C.R., Svrakic D., Faraone S.V., Tsuang M.T. Evidence for the multigenic inheritance of schizophrenia. Am. J. Med. Gen. 105:2001;794-800.
5. Gulbinat W., Dupont A., Jablensky A., Jensen O.M., Marsella A., Nakane Y., Sartorius N. Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries. Br. J. Psychiatry. 161:1992;75-85.
6. Harris A.E. Physical disease and schizophrenia. Schizophr. Bull. 14:1988;85-96.
7. Jablensky A., Lawrence D. Schizophrenia and cancer: is there a need to invoke a protective gene? Arch. Gen. Psychiatry. 58:2001;579-580.
8. Kawajiri K., Nakachi K., Imai K., Watanabe J., Hayashi S. Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis. 14:1993;1085-1089.
9. Lichtermann D., Ekelund J., Pukkala E., Tanskanen A., Lonnqvist J. Incidence of cancer among patients with schizophrenia and their relatives. Arch. Gen. Psychiatry. 58:2001;573-578.
10. Mortensen P.B. The occurrence of cancer in first admitted schizophrenic patients. Schizophr. Res. 12:1994;185-194.
11. Sidransky D., Hollstein M. Clinical implication of the p53 gene. Annu. Rev. Med. 47:1996;285-301.
12. Sullivan P.F., Eaves L.J., Kendler K.S., Neale M.C. Genetic case-control association studies in neuropsychiatry. Arch. Gen. Psychiatry. 58:2001;1015-1024.
13. Xie X., Ott J. Testing linkage disequilibrium between a disease gene and marker loci. Am. J. Hum. Genet. 53:1993;1107.